Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

SKF 86002 (CAS 72873-74-6)

0.0(0)
Write a reviewAsk a question

Alternate Names:
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole
Application:
SKF 86002 is an inhibitor of p53, Cox, and 5-LO
CAS Number:
72873-74-6
Molecular Weight:
297.4
Molecular Formula:
C16H12FN3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

SKF 86002 is a bicyclic imidazole that specifically inhibits p38 MAP kinase, and is also described as a cytokine-suppressant and an anti-inflammatory compound. SKF 86002 has been shown to inhibit Cox (cyclooxygenase) activity and 5-LO (5-lipoxygenase). Osteoblastic cell studies report that SKF 86002 inhibits the production of IL-6. SKF 86002 has been shown to block the activation of TNF-translation and potently inhibit IL-1.


SKF 86002 (CAS 72873-74-6) References

  1. Activation of p38 MAPK induced peroxynitrite generation in LPS plus IFN-gamma-stimulated rat primary astrocytes via activation of iNOS and NADPH oxidase.  |  Yoo, BK., et al. 2008. Neurochem Int. 52: 1188-97. PMID: 18289732
  2. p38 MAPK regulates ischemia-reperfusion-induced recruitment of leukocytes in the colon.  |  Santén, S., et al. 2009. Surgery. 145: 303-12. PMID: 19231583
  3. The effect of dual inhibitor, SK&F 86002, on helper T cell functions.  |  Barton, BE. and James, LC. 1990. Immunopharmacol Immunotoxicol. 12: 105-21. PMID: 2141033
  4. Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.  |  Griswold, DE., et al. 1989. Inflammation. 13: 727-39. PMID: 2559032
  5. Pharmacokinetics and metabolism of SK&F 86002 in male and female Sprague-Dawley rats.  |  Newton, JF., et al. 1989. Drug Metab Dispos. 17: 174-9. PMID: 2565207
  6. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.  |  Griswold, DE., et al. 1987. Biochem Pharmacol. 36: 3463-70. PMID: 2823821
  7. Ovarian effects of SK&F 86002-A2 in the rat: site of action.  |  Walker, RF., et al. 1988. Toxicol Appl Pharmacol. 94: 276-86. PMID: 3388424
  8. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha.  |  Prichett, W., et al. 1995. J Inflamm. 45: 97-105. PMID: 7583362
  9. Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline.  |  Prabhakar, U., et al. 1993. Int J Immunopharmacol. 15: 205-9. PMID: 7682199
  10. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors.  |  Lee, JC., et al. 1993. Ann N Y Acad Sci. 696: 149-70. PMID: 8109825
  11. SK&F 86002, a dual cytokine and eicosanoid inhibitor, attenuates endotoxin-induced cardiopulmonary dysfunction in the pig.  |  Triplett, EA., et al. 1996. Shock. 6: 357-64. PMID: 8946652
  12. Effects of SK&F 86002 on cytokine-stimulated IL6 production in cultured neonatal mouse calvaria and SaOS2 osteoblastic cells: the role of prostaglandins and other mechanisms of action.  |  Blanque, R., et al. 1997. Drugs Exp Clin Res. 23: 63-70. PMID: 9309381
  13. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils.  |  Frasch, SC., et al. 1998. J Biol Chem. 273: 8389-97. PMID: 9525949

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

SKF 86002, 5 mg

sc-203265
5 mg
$153.00